Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites
- PMID: 4084563
- DOI: 10.1021/bi00346a010
Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites
Abstract
The interaction of the antitumor compound adriamycin with negatively charged unilamellar phospholipid vesicles was studied. The negative charges were provided by cardiolipin or phosphatidic acid. By analyzing the changes in the circular dichroism spectrum of adriamycin, we demonstrated the presence of two different spectral patterns corresponding to two different binding sites (I and II) on the vesicles. In site I, the amino sugar of adriamycin is bound to the ionized phosphate of either cardiolipin or phosphatidic acid, and the dihydroxyanthraquinone lies outside the bilayer. In site II, the amino sugar is still bound to the phosphate, but the dihydroxyanthraquinone moiety is embedded in the bilayer. This has been shown by measuring spectroscopically the binding of the aglycon part to an external probe and by measuring the susceptibility of bound adriamycin to reduction by NADH dehydrogenase.
Similar articles
-
Evidence of a specific complex between adriamycin and negatively-charged phospholipids.Biochim Biophys Acta. 1980 Mar 27;597(1):1-14. doi: 10.1016/0005-2736(80)90145-5. Biochim Biophys Acta. 1980. PMID: 7370238
-
Interaction of adriamycin with cardiolipin-containing vesicles. Evidence of an embedded site for the dihydroanthraquinone moiety.Biochim Biophys Acta. 1986 Jan 16;854(1):143-6. doi: 10.1016/0005-2736(86)90074-x. Biochim Biophys Acta. 1986. PMID: 3002460
-
Effects of adriamycin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes.Biochim Biophys Acta. 1985 Sep 25;819(1):55-65. doi: 10.1016/0005-2736(85)90195-6. Biochim Biophys Acta. 1985. PMID: 4041451
-
The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study.Biochim Biophys Acta. 1979 Nov 2;557(2):306-19. doi: 10.1016/0005-2736(79)90329-8. Biochim Biophys Acta. 1979. PMID: 583025
-
Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.Biochim Biophys Acta. 1998 Mar 6;1370(1):31-40. doi: 10.1016/s0005-2736(97)00241-1. Biochim Biophys Acta. 1998. PMID: 9518541
Cited by
-
Combined Second Harmonic Generation and Fluorescence Analyses of the Structures and Dynamics of Molecules on Lipids Using Dual-Probes: A Review.Molecules. 2022 Jun 11;27(12):3778. doi: 10.3390/molecules27123778. Molecules. 2022. PMID: 35744902 Free PMC article. Review.
-
Intracellular distribution of anthracyclines in drug resistant cells.Cytotechnology. 1998 Sep;27(1-3):95-111. doi: 10.1023/A:1008040117882. Cytotechnology. 1998. PMID: 19002786 Free PMC article.
-
Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.Cancer Chemother Pharmacol. 1988;21(4):274-80. doi: 10.1007/BF00264191. Cancer Chemother Pharmacol. 1988. PMID: 3370735
-
Correlation between anthracycline structure and human DNA ligase inhibition.Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):141-6. doi: 10.1042/bj2790141. Biochem J. 1991. PMID: 1930131 Free PMC article.
-
Doxorubicin Inhibits Phosphatidylserine Decarboxylase and Modifies Mitochondrial Membrane Composition in HeLa Cells.Int J Mol Sci. 2020 Feb 15;21(4):1317. doi: 10.3390/ijms21041317. Int J Mol Sci. 2020. PMID: 32075281 Free PMC article.